Hm Payson & CO Invitae Corp Transaction History

Hm Payson & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$6.28 - $15.59 $5,463 - $13,563	-870 Reduced 21.17%	3,240 $26,000
Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $12,789 - $24,942	870 Added 26.85%	4,110 $63,000
Q2 2021 Aug 17, 2021	SELL	$26.09 - $40.4 $45,474 - $70,417	-1,743 Reduced 34.98%	3,240 $109,000
Q4 2020 Mar 10, 2021	SELL	$39.09 - $57.4 $56,367 - $82,770	-1,442 Reduced 22.44%	4,983 $208,000
Q3 2020 Dec 21, 2020	BUY	$28.43 - $44.67 $62,119 - $97,603	2,185 Added 51.53%	6,425 $279,000
Q1 2020 Jul 01, 2020	SELL	$7.64 - $27.5 $756 - $2,722	-99 Reduced 2.28%	4,240 $58,000
Q4 2019 Feb 18, 2020	BUY	$15.02 - $20.57 $65,171 - $89,253	4,339 New	4,339 $70,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.